0.99 USD
▼-0.07-6.27%
盘后 1.00 +0.65%
2026-09-15
市值
$338.57M
市盈率
—
EPS
-0.26
股息率
—
52 周区间
0.98 – 2.73
成交量
12.65M
Beta
2.21
目标价
12.08
52W 低 0.9852W 高 2.73
价格走势
公司简介
Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health. The company’s pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under ...